Literature DB >> 33640146

Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns.

Madhura S Rane1, Libby C Page2, Emma McVeigh2, Kaetlin Miller2, David Baure2, M Elizabeth Halloran3, Jeffrey S Duchin4.   

Abstract

PURPOSE: The aim of this study was to measure the effect of a multicomponent human papillomavirus (HPV) vaccine promotion campaign on adolescent HPV vaccine uptake at school-based health centers (SBHCs) in Seattle, WA.
METHODS: Youth-led HPV vaccine promotion campaigns were introduced in 2016 in 13 schools with SBHCs in Seattle. Five other schools with SBHCs served as controls. Vaccination records for students were obtained from the Washington Immunization Information System from September 2012 to August 2018. We compared increase in HPV vaccine uptake in SBHCs between 1) intervention and control schools, and 2) pre- and post-intervention periods in intervention schools using generalized estimating equations.
RESULTS: HPV vaccine uptake was high at baseline among students that use SBHCs for vaccines and has steadily increased between 2012 and 2018. Implementing the promotion campaign resulted in 14% higher (95% Confidence Interval (CI): 1%, 30%) HPV vaccine uptake in intervention SBHCs compared to control SBHCs, adjusting for time and confounders. Comparing pre-and post-intervention periods in intervention SBHCs, HPV vaccine uptake was 14% higher (95% CI: -4%, 35%) in the post-intervention period. SBHCs that received more active intervention activities saw 9% higher (95% CI: 1%, 21%) vaccine uptake compared to those that received passive intervention.
CONCLUSION: The vaccination promotion program implemented in a school-based setting resulted in higher HPV vaccine uptake in the post-intervention period compared to pre-intervention period, but this increase was not statistically significant. Even so, schools that received more intervention activities for longer periods of time had higher HPV vaccine uptake.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescents; Human papillomavirus; Human papillomavirus vaccine; Immunization registry; School-based health centers

Mesh:

Substances:

Year:  2021        PMID: 33640146      PMCID: PMC8021275          DOI: 10.1016/j.vaccine.2021.02.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  29 in total

1.  Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs.

Authors:  Jessica A Nodulman; Randall Starling; Alberta S Kong; David B Buller; Cosette M Wheeler; W Gill Woodall
Journal:  J Sch Health       Date:  2015-05       Impact factor: 2.118

2.  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Elissa Meites; Allison Kempe; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-16       Impact factor: 17.586

3.  Using a school-based approach to deliver immunization—global update.

Authors:  Jos Vandelaer; Marianne Olaniran
Journal:  Vaccine       Date:  2014-12-15       Impact factor: 3.641

4.  Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.

Authors:  P Goggin; C Sauvageau; V Gilca; F Defay; G Lambert; S Mathieu-C; J Guenoun; E Comète; F Coutlée
Journal:  Hum Vaccin Immunother       Date:  2017-12-13       Impact factor: 3.452

5.  Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years.

Authors:  Sarah E Wilson; Tara Harris; Pam Sethi; Jill Fediurek; Liane Macdonald; Shelley L Deeks
Journal:  Vaccine       Date:  2012-12-13       Impact factor: 3.641

6.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

7.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

Review 8.  Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Authors:  Dawn M Holman; Vicki Benard; Katherine B Roland; Meg Watson; Nicole Liddon; Shannon Stokley
Journal:  JAMA Pediatr       Date:  2014-01       Impact factor: 16.193

9.  Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study.

Authors:  W Ting Lim; Kim Sears; Leah M Smith; Guoyuan Liu; Linda E Lévesque
Journal:  BMC Public Health       Date:  2014-10-03       Impact factor: 3.295

10.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.

Authors:  Tanja Y Walker; Laurie D Elam-Evans; James A Singleton; David Yankey; Lauri E Markowitz; Benjamin Fredua; Charnetta L Williams; Sarah A Meyer; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-08-25       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.